Literature DB >> 21543764

Ghrelin-induced adiposity is independent of orexigenic effects.

Diego Perez-Tilve1, Kristy Heppner, Henriette Kirchner, Sarah H Lockie, Stephen C Woods, David L Smiley, Matthias Tschöp, Paul Pfluger.   

Abstract

Ghrelin is a hormone produced predominantly by the stomach that targets a number of specific areas in the central nervous system to promote a positive energy balance by increasing food intake and energy storage. In that respect, similarities exist with the effects of consuming a high-fat diet (HFD), which also increases caloric intake and the amount of stored calories. We determined whether the effects of ghrelin on feeding and adiposity are influenced by the exposure to an HFD. Chronic intracerebroventricular ghrelin (2.5 nmol/d) increased feeding in lean rats fed a low-fat control diet (CD) [192 ± 5 g (ghrelin+CD) vs. 152 ± 5 g (control i.c.v. saline+CD), P<0.001], but the combination of ghrelin plus HFD did not result in significantly greater hyperphagia [150 ± 7 g (ghrelin+HFD) vs. 136 ± 4 g (saline+HFD)]. Despite failing to increase food intake in rats fed the HFD, ghrelin nonetheless increased adiposity [fat mass increase of 14 ± 2 g (ghrelin+HFD) vs. 1 ± 1 g (saline+HFD), P<0.001] up-regulating the gene expression of lipogenic enzymes in white adipose tissue. Our findings demonstrate that factors associated with high-fat feeding functionally interact with pathways regulating the effect of ghrelin on food intake. We conclude that ghrelin's central effects on nutrient intake and nutrient partitioning can be separated and suggest an opportunity to identify respective independent neuronal pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543764      PMCID: PMC3136335          DOI: 10.1096/fj.11-183632

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  33 in total

1.  Differential sensitivity to central leptin and insulin in male and female rats.

Authors:  Deborah J Clegg; Christine A Riedy; Kathleen A Blake Smith; Stephen C Benoit; Stephen C Woods
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

2.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight.

Authors:  Michael Rosenbaum; Rochelle Goldsmith; Daniel Bloomfield; Anthony Magnano; Louis Weimer; Steven Heymsfield; Dympna Gallagher; Laurel Mayer; Ellen Murphy; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

4.  Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.

Authors:  J Svensson; L Lönn; J O Jansson; G Murphy; D Wyss; D Krupa; K Cerchio; W Polvino; B Gertz; I Boseaus; L Sjöström; B A Bengtsson
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

5.  Distinct forebrain and caudal brainstem contributions to the neuropeptide Y mediation of ghrelin hyperphagia.

Authors:  Lucy F Faulconbridge; Harvey J Grill; Joel M Kaplan
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

6.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.

Authors:  I Sadaf Farooqi; Julia M Keogh; Giles S H Yeo; Emma J Lank; Tim Cheetham; Stephen O'Rahilly
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

7.  Central administration of ghrelin preferentially enhances fat ingestion.

Authors:  Takuya Shimbara; Muhtashan S Mondal; Takashi Kawagoe; Koji Toshinai; Shuichi Koda; Hideki Yamaguchi; Yukari Date; Masamitsu Nakazato
Journal:  Neurosci Lett       Date:  2004-10-07       Impact factor: 3.046

8.  Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle.

Authors:  Rocco Barazzoni; Alessandra Bosutti; Marco Stebel; Maria Rosa Cattin; Elena Roder; Luca Visintin; Luigi Cattin; Gianni Biolo; Michela Zanetti; Gianfranco Guarnieri
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-24       Impact factor: 4.310

9.  Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss.

Authors:  M Perreault; N Istrate; L Wang; A J Nichols; E Tozzo; A Stricker-Krongrad
Journal:  Int J Obes Relat Metab Disord       Date:  2004-07

10.  Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.

Authors:  H Y Chen; M E Trumbauer; A S Chen; D T Weingarth; J R Adams; E G Frazier; Z Shen; D J Marsh; S D Feighner; X-M Guan; Z Ye; R P Nargund; R G Smith; L H T Van der Ploeg; A D Howard; D J MacNeil; S Qian
Journal:  Endocrinology       Date:  2004-02-12       Impact factor: 4.736

View more
  38 in total

1.  Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARγ signaling pathway.

Authors:  Ziru Li; Geyang Xu; Yan Qin; Chao Zhang; Hong Tang; Yue Yin; Xinxin Xiang; Yin Li; Jing Zhao; Michael Mulholland; Weizhen Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release.

Authors:  Blerina Kola; Gábor Wittman; Ibolya Bodnár; Faisal Amin; Chung Thong Lim; Márk Oláh; Mirjam Christ-Crain; Francesca Lolli; Hinke van Thuijl; Chrysanthia A Leontiou; Tamás Füzesi; Paolo Dalino; Andrea M Isidori; Judith Harvey-White; George Kunos; György M Nagy; Ashley B Grossman; Csaba Fekete; Márta Korbonits
Journal:  FASEB J       Date:  2013-08-27       Impact factor: 5.191

3.  Hypothalamic κ-opioid receptor modulates the orexigenic effect of ghrelin.

Authors:  Amparo Romero-Picó; Maria J Vázquez; David González-Touceda; Cintia Folgueira; Karolina P Skibicka; Mayte Alvarez-Crespo; Margriet A Van Gestel; Douglas A Velásquez; Christoph Schwarzer; Herbert Herzog; Miguel López; Roger A Adan; Suzanne L Dickson; Carlos Diéguez; Rubén Nogueiras
Journal:  Neuropsychopharmacology       Date:  2013-01-24       Impact factor: 7.853

Review 4.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.

Authors:  Frederick A Kweh; Jennifer L Miller; Carlos R Sulsona; Clive Wasserfall; Mark Atkinson; Jonathan J Shuster; Anthony P Goldstone; Daniel J Driscoll
Journal:  Am J Med Genet A       Date:  2014-10-29       Impact factor: 2.802

Review 6.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

7.  Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.

Authors:  Rasha Mosa; Lili Huang; Hongzhuo Li; Michael Grist; Derek LeRoith; Chen Chen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-13       Impact factor: 3.619

8.  Differential gene regulation of GHSR signaling pathway in the arcuate nucleus and NPY neurons by fasting, diet-induced obesity, and 17β-estradiol.

Authors:  Ali Yasrebi; Anna Hsieh; Kyle J Mamounis; Elizabeth A Krumm; Jennifer A Yang; Jason Magby; Pu Hu; Troy A Roepke
Journal:  Mol Cell Endocrinol       Date:  2015-11-11       Impact factor: 4.102

Review 9.  Ghrelin: much more than a hunger hormone.

Authors:  Geetali Pradhan; Susan L Samson; Yuxiang Sun
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-11       Impact factor: 4.294

10.  Acylation type determines ghrelin's effects on energy homeostasis in rodents.

Authors:  Kristy M Heppner; Nilika Chaudhary; Timo D Müller; Henriette Kirchner; Kirk M Habegger; Nickki Ottaway; David L Smiley; Richard Dimarchi; Susanna M Hofmann; Stephen C Woods; Bjørn Sivertsen; Birgitte Holst; Paul T Pfluger; Diego Perez-Tilve; Matthias H Tschöp
Journal:  Endocrinology       Date:  2012-08-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.